myelodysplastic syndrome

Categories:

SOP Numbers	Date of Commencement	Incorporated Material	Status
Reasonable Hypothesis	Date of Commencement	Incorporated Material	Status		Balance of Probabilities
73/2015	74/2015	18/09/2017	Guide to Calculation of Cumulative Equivalent Dose ARPANSA 2 August 2017	Current	Compilation

SOP Numbers		Date of Commencement	Status
Reasonable Hypothesis	Balance of Probabilities	Date of Commencement	Status
58/2017 58/2017	58/2017 58/2017	18/09/2017	Current	Amendment
35/2016	36/2016	04/04/2016	Current	Amendment
73/2015 73/2015	74/2015 74/2015	20/07/2015	Current	Principal
previously known as: myelodysplastic disorder
45/2011	46/2011	25/05/2011	Revoked	Amendment
37/2006	38/2006	30/08/2006	Revoked	Principal
15/2000	16/2000	19/07/2000	Revoked	Principal

Subject	Documents	Relevant SOPs	Date
Reference List	Reference list - myelodysplastic syndrome - RMA meeting June 2017	58/2017 58/2017	06/06/2017
Explanatory Statements tabled in Houses of Parliament	SoP Explanatory statement 073 of 2015 RH 293 myelodysplastic syndrome 20 July 2015 SoP Explanatory statement 074 of 2015 BoP 293 myelodysplastic syndrome 20 July 2015	73/2015 74/2015	20/07/2015
Amendment Explanatory Statements tabled in Houses of Parliament	Amendment Determination Explanatory Statement No 58 of 2017 Veterans Entitlements SOPs Cumulative Equivalent Dose 18 September 2017	58/2017 58/2017	18/09/2017